We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

13 hedge funds and large institutions have $1.89M invested in AIM ImmunoTech in 2013 Q2 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
+13
Holders Change %
–
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$811K +$823K +69 New
BIT
2
BlackRock Institutional Trust
California
$496K +$501K +42 New
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$203K +$203K +17 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$126K +$131K +11 New
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$65K +$71.6K +6 New
Northern Trust
6
Northern Trust
Illinois
$54K +$59.6K +5 New
Bank of New York Mellon
7
Bank of New York Mellon
New York
$30K +$35.8K +3 New
Renaissance Technologies
8
Renaissance Technologies
New York
$21K +$23.9K +2 New
State Street
9
State Street
Massachusetts
$19K +$23.9K +2 New
KCG
10
Knight Capital Group
$14K +$11.9K +1 New
GC
11
Guggenheim Capital
Illinois
$10K +$11.9K +1 New
Bank of America
12
Bank of America
North Carolina
$7K +$11.9K +1 New
JIC
13
Joel Isaacson & Co
New York
$7K +$11.9K +1 New
Goldman Sachs
14
Goldman Sachs
New York
$5K – – –
Citadel Advisors
15
Citadel Advisors
Florida
$4K – – –
CS
16
Credit Suisse
Switzerland
$4K – – –
ICAS
17
Investors Capital Advisory Services
Massachusetts
$3K – – –
Two Sigma Investments
18
Two Sigma Investments
New York
$3K – – –
BA
19
BlackRock Advisors
Delaware
$2K – – –
Wells Fargo
20
Wells Fargo
California
$2K – – –
Citigroup
21
Citigroup
New York
$1K – – –

AIM Hedge Fund Activity: Q2 2013 in Review

13 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q2 2013, worth a combined $1.89M.

Buyers outnumbered sellers: 13 funds opened new AIM positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.

  • 13 institutional investors held AIM ImmunoTech (AIM) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.89M of AIM ImmunoTech stock for Q2 2013.
  • 13 funds opened new AIM ImmunoTech positions in Q2 2013 and 0 closed out, a net change of +13 holders.

Based on aggregated 13F filings for Q2 2013.